vs
Side-by-side financial comparison of OPKO HEALTH, INC. (OPK) and PennyMac Mortgage Investment Trust (PMT). Click either name above to swap in a different company.
OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $93.6M, roughly 1.6× PennyMac Mortgage Investment Trust). PennyMac Mortgage Investment Trust runs the higher net margin — 56.0% vs -21.1%, a 77.0% gap on every dollar of revenue. On growth, PennyMac Mortgage Investment Trust posted the faster year-over-year revenue change (-13.3% vs -19.2%). Over the past eight quarters, PennyMac Mortgage Investment Trust's revenue compounded faster (12.3% CAGR vs -7.5%).
OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.
OPK vs PMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $148.5M | $93.6M |
| Net Profit | $-31.3M | $52.4M |
| Gross Margin | 43.1% | — |
| Operating Margin | -25.8% | 38.6% |
| Net Margin | -21.1% | 56.0% |
| Revenue YoY | -19.2% | -13.3% |
| Net Profit YoY | -322.8% | 12.5% |
| EPS (diluted) | $-0.04 | $0.49 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $148.5M | $93.6M | ||
| Q3 25 | $151.7M | $99.2M | ||
| Q2 25 | $156.8M | $70.2M | ||
| Q1 25 | $150.0M | $44.5M | ||
| Q4 24 | $183.6M | $107.9M | ||
| Q3 24 | $173.6M | $80.9M | ||
| Q2 24 | $182.2M | $71.2M | ||
| Q1 24 | $173.7M | $74.2M |
| Q4 25 | $-31.3M | $52.4M | ||
| Q3 25 | $21.6M | $58.3M | ||
| Q2 25 | $-148.4M | $7.5M | ||
| Q1 25 | $-67.6M | $9.7M | ||
| Q4 24 | $14.0M | $46.5M | ||
| Q3 24 | $24.9M | $41.4M | ||
| Q2 24 | $-10.3M | $25.4M | ||
| Q1 24 | $-81.8M | $47.6M |
| Q4 25 | 43.1% | — | ||
| Q3 25 | 32.9% | — | ||
| Q2 25 | 31.5% | — | ||
| Q1 25 | 28.4% | — | ||
| Q4 24 | 46.1% | — | ||
| Q3 24 | 23.1% | — | ||
| Q2 24 | 28.4% | — | ||
| Q1 24 | 24.2% | — |
| Q4 25 | -25.8% | 38.6% | ||
| Q3 25 | 31.7% | 47.4% | ||
| Q2 25 | -38.3% | 24.2% | ||
| Q1 25 | -44.8% | -14.2% | ||
| Q4 24 | -18.0% | 51.1% | ||
| Q3 24 | 8.2% | 32.8% | ||
| Q2 24 | -33.9% | 40.2% | ||
| Q1 24 | -41.2% | 43.6% |
| Q4 25 | -21.1% | 56.0% | ||
| Q3 25 | 14.3% | 58.7% | ||
| Q2 25 | -94.7% | 10.7% | ||
| Q1 25 | -45.1% | 21.8% | ||
| Q4 24 | 7.6% | 43.1% | ||
| Q3 24 | 14.3% | 51.2% | ||
| Q2 24 | -5.7% | 35.7% | ||
| Q1 24 | -47.1% | 64.2% |
| Q4 25 | $-0.04 | $0.49 | ||
| Q3 25 | $0.03 | $0.55 | ||
| Q2 25 | $-0.19 | $-0.04 | ||
| Q1 25 | $-0.10 | $-0.01 | ||
| Q4 24 | $0.02 | $0.45 | ||
| Q3 24 | $0.03 | $0.36 | ||
| Q2 24 | $-0.01 | $0.17 | ||
| Q1 24 | $-0.12 | $0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $364.4M | $190.5M |
| Total DebtLower is stronger | $344.0M | $1.1B |
| Stockholders' EquityBook value | $1.3B | $1.9B |
| Total Assets | $1.9B | $21.3B |
| Debt / EquityLower = less leverage | 0.27× | 0.58× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $364.4M | $190.5M | ||
| Q3 25 | $412.0M | $181.0M | ||
| Q2 25 | $267.3M | $108.6M | ||
| Q1 25 | $428.8M | $204.2M | ||
| Q4 24 | $426.6M | $103.2M | ||
| Q3 24 | $400.1M | $102.8M | ||
| Q2 24 | $40.6M | $336.3M | ||
| Q1 24 | $75.6M | $343.3M |
| Q4 25 | $344.0M | $1.1B | ||
| Q3 25 | $344.2M | $299.0M | ||
| Q2 25 | $343.3M | $1.2B | ||
| Q1 25 | $439.2M | $968.4M | ||
| Q4 24 | $437.2M | $1.0B | ||
| Q3 24 | $441.0M | $5.2B | ||
| Q2 24 | $201.9M | $5.4B | ||
| Q1 24 | $350.1M | $5.1B |
| Q4 25 | $1.3B | $1.9B | ||
| Q3 25 | $1.3B | $1.9B | ||
| Q2 25 | $1.3B | $1.9B | ||
| Q1 25 | $1.3B | $1.9B | ||
| Q4 24 | $1.4B | $1.9B | ||
| Q3 24 | $1.4B | $1.9B | ||
| Q2 24 | $1.4B | $1.9B | ||
| Q1 24 | $1.3B | $2.0B |
| Q4 25 | $1.9B | $21.3B | ||
| Q3 25 | $2.0B | $18.5B | ||
| Q2 25 | $2.0B | $16.8B | ||
| Q1 25 | $2.1B | $14.9B | ||
| Q4 24 | $2.2B | $14.4B | ||
| Q3 24 | $2.3B | $13.1B | ||
| Q2 24 | $2.0B | $12.1B | ||
| Q1 24 | $2.0B | $12.3B |
| Q4 25 | 0.27× | 0.58× | ||
| Q3 25 | 0.26× | 0.16× | ||
| Q2 25 | 0.26× | 0.65× | ||
| Q1 25 | 0.33× | 0.51× | ||
| Q4 24 | 0.32× | 0.52× | ||
| Q3 24 | 0.31× | 2.70× | ||
| Q2 24 | 0.14× | 2.76× | ||
| Q1 24 | 0.28× | 2.60× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-25.9M | $-7.2B |
| Free Cash FlowOCF − Capex | $-28.6M | — |
| FCF MarginFCF / Revenue | -19.3% | — |
| Capex IntensityCapex / Revenue | 1.8% | — |
| Cash ConversionOCF / Net Profit | — | -137.76× |
| TTM Free Cash FlowTrailing 4 quarters | $-190.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-25.9M | $-7.2B | ||
| Q3 25 | $-34.6M | $-1.3B | ||
| Q2 25 | $-83.4M | $-2.0B | ||
| Q1 25 | $-34.6M | $-594.3M | ||
| Q4 24 | $-44.4M | $-2.7B | ||
| Q3 24 | $-77.1M | $-983.8M | ||
| Q2 24 | $-26.4M | $243.8M | ||
| Q1 24 | $-35.6M | $-342.4M |
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-37.8M | — | ||
| Q2 25 | $-86.7M | — | ||
| Q1 25 | $-37.7M | — | ||
| Q4 24 | $-49.8M | — | ||
| Q3 24 | $-85.0M | — | ||
| Q2 24 | $-33.7M | — | ||
| Q1 24 | $-40.0M | — |
| Q4 25 | -19.3% | — | ||
| Q3 25 | -24.9% | — | ||
| Q2 25 | -55.3% | — | ||
| Q1 25 | -25.2% | — | ||
| Q4 24 | -27.1% | — | ||
| Q3 24 | -49.0% | — | ||
| Q2 24 | -18.5% | — | ||
| Q1 24 | -23.0% | — |
| Q4 25 | 1.8% | — | ||
| Q3 25 | 2.1% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 2.9% | — | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 2.6% | — |
| Q4 25 | — | -137.76× | ||
| Q3 25 | -1.60× | -22.26× | ||
| Q2 25 | — | -267.53× | ||
| Q1 25 | — | -61.39× | ||
| Q4 24 | -3.17× | -58.08× | ||
| Q3 24 | -3.10× | -23.76× | ||
| Q2 24 | — | 9.59× | ||
| Q1 24 | — | -7.19× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
OPK
| Services | $71.1M | 48% |
| Transfer Of Intellectual Property And Other | $33.7M | 23% |
| IE | $22.1M | 15% |
| Rayaldee | $8.8M | 6% |
| Barda Agreement | $6.8M | 5% |
| MX | $6.3M | 4% |
PMT
| Other | $55.0M | 59% |
| Interest Rate Sensitive Strategies | $31.4M | 34% |
| Correspondent Production | $7.2M | 8% |
